Over the years the European Medicines Regulatory Network has collected a wealth of data about clinical trials through their clinical trials registers, CTIS and EudraCT.
These data are used to support regulatory decision-making, though their potential uses extend far beyond that scope. Stakeholders may have diverse interests, from locating trials for certain health conditions to monitoring innovation in healthcare and even applying Artificial Intelligence for novel insights. While these data hold immense potential, they still pose challenges in access and usability.
Aiming to overcome these challenges, the initiative engaged stakeholders via a workshop to understand how data about clinical trials can address their needs. The workshop will result in the publication of a research agenda on clinical trial analytics which will guide regulatory action and may influence future public funding calls.
By highlighting research needs and facilitating analysis of clinical trial data, ACT EU will help address key challenges in the EU clinical trials environment.
Trial Map
A map of clinical trials, integrated with the public portal of the Clinical Trials Information System (CTIS), emerged as a key request from the ACT EU workshop on clinical trials analytics in January 2024. Stakeholders highlighted the need for a simple dashboard that patients and healthcare professionals can use to easily locate clinical trials of interest in the EU.
For this purpose, ACT EU developed the Trial Map, a tool designed to empower patients by providing them with easy access to comprehensive information about clinical trials in their area.
The map:
- Makes it easier to find trials by geographic area and medical condition by enabling searches in lay language (through the Consumer Health Vocabulary);
- Helps patients to locate trials of interest which they can discuss with their healthcare professionals.
Find clinical trials near you on the CTIS website: Trial Map
Documents
